Clinical Trials Logo

Clinical Trial Summary

Research study which tests the safety and effectiveness of a new vascular closure device to close the femoral access puncture that is created in patients who require this form of access in order to perform the planned procedure. The MANTA device is expected to seal the femoral access puncture in less than 1 minute. This may result in less blood loss and a shorter time to walking compared to alternative closure means. Use of the MANTA device in this study is experimental. All other parts of the procedure involve standard medical care.


Clinical Trial Description

The MANTA device is a VCD intended for use in catheterization laboratories following percutaneous cardiac or peripheral procedures that use the retrograde common femoral artery access route for large bore (10‐18F ID) interventional devices. The function of MANTA is to percutaneously close the puncture in the artery wall (arteriotomy) through which the catheters were inserted for the procedure.

The study is being conducted to demonstrate the safety and effectiveness of MANTA in achieving hemostasis in femoral arterial access sites in subjects undergoing percutaneous transcatheter interventional procedures using a large-bore procedure sheath. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02908880
Study type Interventional
Source Essential Medical, Inc.
Contact
Status Completed
Phase N/A
Start date December 2016
Completion date December 2017

See also
  Status Clinical Trial Phase
Recruiting NCT05936996 - Prospective Clinical Registry Evaluating Contemporary MANTA Outcomes
Not yet recruiting NCT06358157 - The Ladera Large Bore Closure Feasibility Study N/A
Completed NCT02521948 - Clinical Study to Evaluate the Safety and Performance of MANTA Vascular Closure Device N/A
Completed NCT03330002 - MANTA Registry for Vascular Large-bore Closure
Terminated NCT05142566 - MANTA Ultrasound Closure Study N/A
Completed NCT02406612 - X-Seal EU Post-Market Clinical Follow-Up Protocol N/A